Biodesix, Inc. (BDSX) vs Niagen Bioscience Inc (NAGE)

A side-by-side comparison of Biodesix, Inc. and Niagen Bioscience Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BDSX vs NAGE

growth of $100 · dividends reinvested · last 6y
BDSX -88.7% (-30.4%/yr)NAGE -44.4% (-9.3%/yr)NAGE compounded faster over this window
0100200300Start $100202120222023202420252026$11$56
BDSX NAGE

BDSX vs NAGE: by the numbers

  • •BDSX is the larger company ($231M vs $215M market cap).
  • •NAGE is profitable (12.39% net margin) while BDSX runs a net loss (-26.97%).
  • •NAGE grew revenue faster over the past five years (15.80% vs 5.99% CAGR).

Metrics side by side

Valuation

MetricBDSXNAGE
P/E ratioN/A14.45
Forward P/EN/A18.68
P/S ratio2.241.66
P/B ratio25.262.60
EV / EBITDAN/A14.38
FCF yieldN/A2.65%

Profitability

MetricBDSXNAGE
Gross margin82.50%64.24%
Operating margin-31.37%6.67%
Net margin-26.97%12.39%
ROE-303.61%19.38%
ROIC-25.73%8.84%

Growth (annualized)

MetricBDSXNAGE
Revenue CAGR (5Y)5.99%15.80%
Total return CAGR (5Y)-28.49%-15.72%

Frequently asked

Which has grown faster, BDSX or NAGE?
Over the past five years, NAGE grew revenue faster — BDSX at a 5.99% CAGR versus NAGE at 15.80%.
Is BDSX or NAGE more profitable?
NAGE runs the higher net margin — BDSX at -26.97% versus NAGE at 12.39%.
How have BDSX and NAGE total returns compared?
Over the past 5 years, BDSX delivered -28.49% and NAGE delivered -15.72% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.